Immune-Related Adverse Events from Cancer Immunotherapy

Part of the Surgical Grand Rounds Series - Jarushka Naidoo, MB, BCh identifies the spectrum of toxicities from cancer immunotherapy and presents the features and management CAR T-cell toxicities.  Dr Naidoo also describes the features and management of immune checkpoint inhibitor toxicities and analyzes why some fatal toxicities occur. 

 


Created by

Johns Hopkins Greater Washington Area

Related Presenters

Jarushka Naidoo, M.B.B.Ch.

Jarushka Naidoo, M.B.B.Ch.

Assistant Professor of Oncology

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Bloomberg-Kimmel Institute for Cancer Immunotherapy

View full profile